MedDevNews, Q4 2021
Following the trend of the last few quarters, the medical device sector still demonstrated high levels of M&A and financing activity in Q4, despite a downtick from the previous year. Less than half of our tracked sectors in the medical device space witnessed positive stock price momentum versus the S&P 500, signaling an industry correction from the pandemic highs. Multiple sectors still outperformed, however, including aesthetics, lab diagnostics, and radiation therapy. Transaction levels indicated a high degree of stability, tracking roughly with Q3.
